🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Will Chicken Segment Drive Tyson Foods' (TSN) Q3 Earnings?

Published 08/02/2019, 08:50 AM
Updated 07/09/2023, 06:31 AM
GIS
-
KHC
-
MKC
-
EL
-
TSN
-
BYND
-

Tyson Foods, Inc. (NYSE:TSN) is scheduled to release third-quarter fiscal 2019 results on Aug 5. This renowned meat products company’s earnings have outpaced the Zacks Consensus Estimate, with average of 10.2% in the trailing four quarters.

Let’s see what’s in store for the company this time around.

McCormick & Company (NYSE:MKC), Incorporated Price and EPS Surprise



McCormick & Company, Incorporated Price and EPS Surprise

McCormick & Company, Incorporated price-eps-surprise | McCormick & Company, Incorporated Quote

What to Expect?

The Zacks Consensus Estimate for earnings in the third quarter has remained unchanged in the past 30 days at $1.47, indicating a decline from $1.50 reported in the year-ago quarter. The consensus mark for revenues is $11,108 million, implying an increase of 10.5% from the year-ago quarter’s reported figure.

Factors Likely to Drive Tyson Foods

Tyson Foods is likely to gain from its Chicken and Beef segments, given the rising demand for protein. Notably, the company boasts a rich portfolio of protein-packed brands, the demand for which is growing rapidly across the globe. To this end, the company has also been undertaking acquisitions alongside offloading certain non-protein businesses. In particular, acquisitions are aiding growth in the Chicken segment and are likely to be a key driver in the quarter to be reported. Notably, the company acquired the Keystone Foods business in November 2018, which is expected to keep bolstering its Chicken and Other segments' performance.

Other notable acquisitions of Tyson Foods in the past include AdvancePierre and Original Philly Holdings. Also, the company has acquired poultry rendering and blending assets of AMPRO Products, Inc. and American Proteins, Inc. This has enabled Tyson Foods to bolster animal products recycling capabilities, which will aid in expanding the animal feed business. Apart from this, the company is likely to benefit from its focus on alternative sources for meat and protein products, evident from its investments in Beyond Meat (NASDAQ:BYND) and Memphis Meats.

Hurdles in the Path

Lower sales in the Pork and Prepared Foods categories have been weighing on the company’s top-line performance. While Pork segment sales were hurt by lower average sale price, the performance of the Prepared Foods category has been bearing the brunt of business divestitures. Also, input costs in the Prepared Foods category are expected to rise during the third and fourth quarters of fiscal 2019, owing to higher price of beef and pork stemming from the concerns regarding the outbreak of African swine fever in China. This poses a threat to the bottom line.

What the Zacks Model Unveils

Our proven model doesn’t conclusively predict a beat for Tyson Foods this earnings season. For this to happen, a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Though Tyson Foods carries a Zacks Rank #3, it has an Earnings ESP of 0.00%, which makes surprise prediction difficult.

Stocks Poised to Beat Earnings Estimates

Estee Lauder (NYSE:EL) currently has an Earnings ESP of +2.46% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

General Mills (NYSE:GIS) presently has an Earnings ESP of +0.97% and a Zacks Rank #2.

Kraft Heinz (NASDAQ:KHC) currently has an Earnings ESP of +2.67% and a Zacks Rank #3.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



The Estee Lauder Companies Inc. (EL): Free Stock Analysis Report

Tyson Foods, Inc. (TSN): Free Stock Analysis Report

General Mills, Inc. (GIS): Free Stock Analysis Report

The Kraft Heinz Company (KHC): Free Stock Analysis Report

Original post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.